AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Novalac has 9.2 points more BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Novalac (novalac.com)
Novalac presents a ‘Broken Template’ profile where marketing ambition is sabotaged by technical neglect. The literal ‘0’ values for clinical trials on the homepage and the reliance on decades-old citations create a ‘trust vacuum’ that its specific ingredient lists cannot entirely fill. It is a site that talks like a biotech firm but maintains itself like a neglected landing page.
Immediately fix the ‘+0’ technical placeholders on the homepage to reflect actual verified numbers of trials and quality controls. Update the scientific bibliography by replacing the 2003 Bocquet citation with peer-reviewed studies from 2021-2026 to prove contemporary relevance. Implement ‘Organization’ and ‘Product’ JSON-LD schema to provide search engines and users with a verifiable corporate identity. Translate all remaining French fragments in the footer to ensure linguistic consistency across the English site.
The heading fluff saturation is moderate, with phrases like ‘by your side to help your child grow’ and ‘When all is well’ serving as emotional filler. While the body text contains specific technical nouns such as ‘Bifidobacterium animalis subsp.lactis’ and ‘Galacto-oligosaccharides,’ the homepage contains egregious substance voids. Specifically, the ‘Good reasons to partner’ section displays ‘+0 clinical trials’ and ‘+0 quality controls,’ which are clearly broken technical placeholders that provide zero information density.
If your @id chain is broken, your entire knowledge graph collapses into isolated nodes. Check your AI visible entity graph with a free one page structured data interpretation.
There is a notable disconnect between the homepage’s positioning as a healthcare-benefit provider (‘Latin for new milk’) and the sub-page reality of standard formula marketing. The homepage promises ‘clinical trials and studies’ as a key reason to partner, yet the only scientific citation provided on the sub-pages is a 2003 study (Bocquet A., et al.), creating a drift between the claim of ongoing innovation and the stale evidence actually presented. Messaging consistency is also hampered by the presence of French phrases like ‘Dernières actualités’ on an English-language site.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The site exhibits high trust theatre with a review_count of up to 28 on sub-pages but a proof_links_count of 0, meaning reviews are presented without verifiable third-party sources. It makes bold claims of being a ‘pioneer in the management of Cow’s Milk Allergy’ without linking to patents, awards, or historical timelines. The trust_theatre_flag is true on all primary pages, indicating a reliance on unverified social proof rather than documented evidence.
Specific evidence is concentrated in ingredient lists (ARA, DHA, Nucleotides), but the ratio of proof to assertion is low. For every technical specification of a formula, there are multiple vague assertions like ‘innovative and unique’ or ‘healthcare benefit’ that lack citations. The reliance on a single citation from 2003 (23 years old relative to the audit date) represents a stale proof density that fails to support claims of ‘breakthrough innovation.’
To examine how structural entropy affects chunking and retrieval, review the Moz Semantic HTML audit. View the Moz Semantic HTML Audit for a complete example of heading logic, landmark integrity, and DOM depth diagnostics.
The site uses several industry clichés such as ‘nutritionally complete’ and ‘specially developed by experts,’ which are standard in the infant formula category. Template language is highly visible in the footer sections, where placeholders like ‘Article 5’ and generic headings like ‘In a few words’ remain unpopulated with unique brand content. The value proposition of ‘growing-up milk’ vs ‘cow’s milk’ is a common industry trope that lacks a unique brand-specific angle beyond the fruit flavors.
There is a significant technical credibility gap; the homepage has null schema_json and sub-pages utilize only basic BreadcrumbList, failing to define the brand as an Organization or its formulas as Products. While ‘Cécile Déturche’ is named as a Dietitian, there is no Person schema or sameAs links to verify her credentials or professional footprint. The presence of ‘+0’ placeholders suggests a lack of technical oversight, which undermines the brand’s claim of ‘Quality at the heart of our concerns.’
The homepage claims ‘+400 M meals per year worldwide’ and presence in ‘more than 60 countries,’ yet fails to provide a link to a corporate report or a map of operations to substantiate these high-level figures. The claim of ‘clinical trials performed’ is literally contradicted by the ‘+0’ count displayed immediately below it. This creates a severe disconnect between the brand’s intended status as a scientific leader and the data it actually demonstrates.
Medical Devices, Pharma & Biotech BS: Novalac (novalac.com)
The site aligns with the Medical Devices, Pharma & Biotech sector through its focus on pediatric nutrition, clinical trial claims, and participation in ESPGHAN. However, the marketing of infant formula involves specific regulatory constraints that are visible in the mandatory breastfeeding disclaimers found across all sub-pages.
A page that loads perfectly for users can still return an empty shell to an AI crawler. Examine the Crawlability Technical Guide and understand why script free extraction is the real measure of visibility.
“The BS score of 50 reflects a site in 'Technical and Proof Limbo.' The Information Density and Identity pillars suffered most due to broken placeholders (+0 trials) and the lack of structured data. While the product specs themselves contain legitimate substance, the framework surrounding them is built on 'Trust Theatre' and unverified authority claims.”